SANGAMO THERAPEUTICS, INC insider trading

SGMOQOTC

$0.14-0.01 (-6.67% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-80.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

SMSandy MacraePRESIDENT, CEO AND DIRECTOR0.4574%of company
PDPrathyusha DuraibabuPRINCIPAL FINANCIAL OFFICER0.1593%of company
SBScott B. WilloughbySVP, CHIEF LEGAL OFFICER, SECY0.1563%of company
NDNathalie Dubois-StringfellowSVP-CHIEF DEVELOPMENT OFFICER0.0793%of company
NJNikunj JainPrincipal Accounting Officer0.0568%of company
GDGregory D. DavisHead of Research & Technology0.0274%of company
HSH. Stewart ParkerDirector0.0272%of company
KLKaren L. SmithDirector0.0246%of company
RCRobert CareyDirector0.024%of company
JRJames R. MeyersDirector0.024%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
SGMOQ	Gregory D. DavisHead of Research & Technology	Open market sell$17.5K	-37.7%	$0.25	$17.5K	Apr 22, 2026	Apr 23, 2026
SGMOQ	Nathalie Dubois-StringfellowSVP-CHIEF DEVELOPMENT OFFICER	Open market sell$89.9K	-51.0%	$0.26	$89.9K	Apr 21, 2026	Apr 23, 2026

End of history · 2 transactions